• Forschungsschwerpunkte

    • Informatik in der klinischen und translationalen Forschung
    • Single-Source-Informationssysteme
    • Integrierte Analyse von molekularen und klinischen Daten
  • Vita

    Akademische Ausbildung

    Weiterbildungsbefugnis für Medizinische Informatik der Ärztekammer Westfalen-Lippe
    Zertifikat Biometrie der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie
    Habilitation, Erlangung der Venia legendi für Medizinische Informatik an der Ludwig-Maximilians-Universität München, Habilitationsthema: "Die Analyse der Datenqualität und -komplexität in Medizinischen Datenbanken"
    Zertifikat Medizinische Informatik der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie
    Diplom in Informatik
    -
    Studium der Informatik an der FU Hagen
    Approbation als Arzt
    Promotion zum Dr. med. an der TU München, Dissertationsthema: "Entwicklung einer computergestützten Ganzzell- und Einzelkanal-Analyse"
    -
    Studium der Humanmedizin an der Technischen Universität München mit Auslandsaufenthalten in Zürich, London und Montpellier

    Beruflicher Werdegang

    seit
    Managing Director of the Department of Medical Informatics and Biomathematics at the University of Münster
    seit
    Mitglied der IV-Kommission an der Westfälischen Wilhelms-Universität Münster
    -
    Leiter der Abteilung Klinische Systeme des Universitätsklinikums Münster (UKM)
    seit
    Professor für Medizinische Informatik am Institut für Medizinische Informatik und Biomathematik der Westfälischen Wilhelms-Universität Münster
    -
    Mitarbeiter im Bereich Industrieforschung für Krankenhausinformationssysteme bei Siemens Medical Health Services, USA
    -
    IT-Beauftragter der Munich-Harvard Alliance for Medical Education der Ludwig-Maximilians-Universität München
    -
    Wissenschaftlicher Mitarbeiter am Institut für Medizinische Informatik, Biometrie und Epidemiologie der Ludwig-Maximilians-Universität München

    Preise

    Best Poster Award 2019 - 8. Kongress des Dachverbandes Reproduktionsbiologie und -medizin (DVR)

    Mitgliedschaften und Aktivitäten in Gremien

    seit
    Mitglied im Gutachtergremium im Bereich "eHealth" für die Europäischen Kommission
     
    Mitglied der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS)
  • Projekte

    • COMPASS - Coordination on mobile pandemic apps best practice and solution sharing ()
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01KX2021
    • CODEX - COVID-19 Data Exchange Platform ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01KX2021
    • Smart Device System für Bewegungsstörungen ( - )
      Drittmittel: Innovative Medizinische Forschung | Förderkennzeichen: VA 111809
    • SOLKID-GNR - Die Sicherheit des Lebendnierenspenders - das deutsche nationale Register (Realisierungsphase) ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01GY1906
    • HiGHmed - HiGHmed – Medizininformatik-Initiative Deutschland ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01ZZ1802V
    • PRUSEARCH - FOR 2690: Translationale Pruritusforschung - TP: Zentrale Informationsinfrastruktur, Bioinformatik und Physische Biomaterial Bank ( - )
      Drittmittel: DFG - Forschungsgruppe | Förderkennzeichen: BR 5841/1-1
    • MDM-Portal - Portal für Medizinische Datenmodelle ( - )
      Drittmittel: DFG - Sachbeihilfe/Einzelförderung | Förderkennzeichen: DU 352/11-2
    • Epigenetische Basis der Plastizitätseigenschaften und Therapieresistenz von T-Linien-abgeleiteten myeloischen Leukämiestammzellen ( - )
      Drittmittel: Deutsche Krebshilfe e.V. | Förderkennzeichen: 70112660
    • KFO 326 - Male Germ Cells: from Genes to Function - CP: Koordination und integrierte Analyse von OMICs-Daten ( - )
      Drittmittel: DFG - Klinische Forschungsgruppe | Förderkennzeichen: TU 298/5-1
    • Infektionsbedingte Mutationsprofile in pB-ALL ( - )
      Drittmittel: Deutsche Kinderkrebsstiftung e.V. | Förderkennzeichen: DKS 2016.17
    • MDS-RIGHT - Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time (MDS-RIGHT) ( - )
      Drittmittel: EU H2020 - Research and innovation actions | Förderkennzeichen: 634789
    • PPRC - European Prurigo Project ( - )
      Drittmittel: European Academy of Dermatology and Venereology | Förderkennzeichen: 2016012
    • PTPR - PTPR - Molekulare Charakterisierung von papillären Tumoren der Pinealisregion ( - )
      Drittmittel: Innovative Medizinische Forschung | Förderkennzeichen: TH 111807
    • T.I.M.E. - Telemedizinische Information bei Medizinsichen Notfällen ( - )
      Drittmittel: EU - Europäischer Fonds für regionale Entwicklung | Förderkennzeichen: EFRE-0800196
    • Erwerbstätigkeit und Lebensqualität bei Patienten mit malignem Melanom ( - )
      Drittmittel: Deutsche Rentenversicherung Westfalen | Förderkennzeichen: 622-4012
    • Molekulargenetische Charakterisierung von lymphoblastischen T-Zell Lymphomen im Kindes- und Jugendalter ( - )
      Drittmittel: Deutsche Krebshilfe e.V. | Förderkennzeichen: 111347
    • SOLKID-GNR - Die Sicherheit des Lebendspenders - Das Deutsche Nationale Lebendspende Register - Konzeptentwicklung ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01GY1725
    • MDM-Portal - Portal für Medizinische Datenmodelle ( - )
      Drittmittel: DFG - Sachbeihilfe/Einzelförderung | Förderkennzeichen: DU 352/11-1
    • PruNet - European Network on Asessment of Severity and Burden of Pruritus ( - )
      Drittmittel: European Academy of Dermatology and Venereology | Förderkennzeichen: 2014-022
    • Role of the three-dimensional chromatin structure in expression control of the tumor suppressor gene PU.1 ( - )
      Unbekannte Mittelart: Interdisziplinäres Zentrum für Klinische Forschung Münster | Förderkennzeichen: Ros2/007/15
    • ADMIRE - AgenDa Medical Informatics for healthcare, Research & Education ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01ZZ1602B
    • x4T-EDC - x4T-EDC (Exchange for Trials) (seit )
      Eigenmittel
    • TRIAGE-MDS - TRIAGE-MDS: Translationale Implementierung von Genetischer Evidenz beim Management von MDS ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01KT1401
    • Eine Phase-II-Studie zur Erfassung der Effektivität einer Therapie mit ATRA und TCP bei Patienten mit Erstdiagnose einer akuten myeloischen Leukämie ( - )
      Drittmittel: Deutsche Krebshilfe e.V. | Förderkennzeichen: 110500
    • Verbesserung der Diagnostik von Tumorerkrankungen durch neue DNA-Sequenzierverfahren und Algorithmen ( - )
      Drittmittel: Deutsche Krebshilfe e.V. | Förderkennzeichen: 110807; 110495
    • NFDM-Sprint Forschungsprojekt zur Einführung der Fachanwendung Notfalldaten-Management (NFDM) der elektronischen Gesundheitskarte (eGK). ()
      Eigenmittel
    • MA-RIKA - Medizinisches Akutkrankenhaus. Rettungsdienst Informations- und Kommunikationssystem für akute Notfälle im Alter ( - )
      Drittmittel: Ministerium für Gesundheit, Emanzipation, Pflege und Alter des Landes Nordrhein-Westfalens | Förderkennzeichen: 005-GW03-114A
    • FOR 1336 - Von Monozyten bis zu Hirnmakrophagen -Einflüsse auf die Eigenschaften myeloider Zellen im Gehirn - A3: Rolle des Transkriptionsfaktors PU.1 für die Differenzierung und Funktion peripherer Makrophagen ( - )
      Drittmittel: DFG - Forschungsgruppe | Förderkennzeichen: RO 2295/4-2
    • SHT-Register - Klinisches Register für Patientinnen und Patienten mit Schädelhirntrauma ( - )
      Drittmittel: EU - Europäischer Fonds für regionale Entwicklung | Förderkennzeichen: 005-GW02-024
    • EHR4CR - Elektronische Patientenakten-Systeme für die klinische Forschung ( - )
      Drittmittel: IMI Innovative Medicines Initiative
    • Identifizierung molekulargenetischer Prognosefaktoren bei TEL/AML1+ akuter lymphoblastischer Leukämie des Kindesalters ( - )
      Drittmittel: Deutsche Kinderkrebsstiftung e.V. | Förderkennzeichen: DKS2010.21
    • MoPat - MoPat (Mobile Patientenfragebögen) (seit )
      Eigenmittel
    • EuGESMA - European Genomics and Epigenomics - Translating Genomic and epigenetic Studies of MDS and AML ( - )
      Drittmittel: EU - COST Actions | Förderkennzeichen: BM0801
    • Integrierte klinische Informationssysteme nach dem Single-Source-Konzept ( - )
      Drittmittel: DFG - Sachbeihilfe/Einzelförderung | Förderkennzeichen: DU 352/5-1
    • Telematische Unterstützung der Schwerverletztenversorgung ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 005-GW01-128A
    • Leukemia Gene Atlas - ein integriertes System für molekulare und klinische Daten zur Unterstützung der translationalen Leukämieforschung ( - )
      Drittmittel: José Carreras Leukämie-Stiftung | Förderkennzeichen: DJCLS H 09/04
    • Verbund: KIS-basierte Unterstützung der Patientenrekrutierung in klinischen Studien - Teilprojekt der Uni Münster ( - )
      Drittmittel: Bundesministerium für Bildung und Forschung | Förderkennzeichen: 01EZ0941A
    • EUROPEAN LEUKEMIANET - Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe ( - )
      Drittmittel: EU FP 6 - Networks of Excellence | Förderkennzeichen: 503216
  • Publikationen

    • Krenz H, Gromoll J, Darde T, Chalmel F, Dugas M, Tüttelmann F. . ‘The Male Fertility Gene Atlas: a web tool for collecting and integrating OMICS data in the context of male infertility.’ Human Reproduction 35, Nr. 9. doi: 10.1093/humrep/deaa155.
    • Leitão E, Di Persio S, Laurentino S, Wöste M, Dugas M, Kliesch S, Neuhaus N, Horsthemke B. . ‘The sperm epigenome does not display recurrent epimutations in patients with severely impaired spermatogenesis.’ Clinical Epigenetics 121, Nr. 1: 61. doi: 10.1186/s13148-020-00854-0.
    • Sandmann S, Wöste M, Graaf AO, Burkhardt B, Jansen JH, Dugas M. . ‘CopyDetective: Detection threshold-aware copy number variant calling in whole-exome sequencing data.’ GigaScience 9, Nr. 11. doi: 10.1093/gigascience/giaa118.
    • Schubert M, Kaldewey S, {Pérez Lanuza}} L, Krenz H, Dugas M, Berres S, Kliesch S, Wistuba J, Gromoll J. . ‘Does the FSHB c.-211G{\textgreater}T polymorphism impact Sertoli cell number and the spermatogenic potential in infertile patients?Andrology 8, Nr. 5: 1030-1037. doi: 10.1111/andr.12777.
    • Reichenpfader D, Glauser R, Dugas M, Denecke K. . ‘Assessing and Improving the Usability of the Medical Data Models Portal.’ Studies in health technology and informatics 271: 199-206.
    • Richter MF, Storck M, Blitz R, Goltermann J, Seipp J, Dannlowski U, Baune BT, Dugas M, Opel N. . ‘Repeated digitised assessment of risk and symptom profiles during inpatient treatment for affective disorders: Observational study.’ JMIR Mental Health 7.
    • Troschel FM, Ramroth C, Lemcke L, Clasing J, Troschel AS, Dugas M, Stummer W, Wiewrodt R, Brandt R, Wiewrodt D. . ‘Feasibility, Safety and Effects of a One-Week, Ski-Based Exercise Intervention in Brain Tumor Patients and Their Relatives: A Pilot Study.’ Journal of clinical medicine 9, Nr. 4. doi: 10.3390/jcm9041006.
    • Holstein J, Solimani F, Baum C, Meier K, Pollmann R, Didona D, Tekath T, Dugas M, Casadei N, Hudemann C, Polakova A, Matthes J, Schäfer I, Yazdi AS, Eming R, Hertl M, Pfützner W, Ghoreschi K, Möbs C. . ‘Immunophenotyping in pemphigus reveals a T17/T17 cell-dominated immune response promoting desmoglein1/3-specific autoantibody production.’ The Journal of allergy and clinical immunology 2020. doi: 10.1016/j.jaci.2020.11.008.
    • Fechner M, Brix TJ, Hardt T, Oehm J, Dugas M, Storck M. . ‘Evaluation of openEHR Repositories Regarding Standard Compliance.’ Studies in health technology and informatics 270: 592-596.
    • Reutter K, Sandmann S, Rohde J, Müller S, Wöste M, Khanam T, Michgehl U, Klapper W, Wö{ß}mann W, Seggewi{ß} J, Lenz G, Dugas M, Burkhardt B. . ‘Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma.’ Leukemia 2020.
    • Wünsch C, Banck H, Müller-Tidow C, Dugas M. . ‘AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.’ BMC medical genomics 13, Nr. 1: 17.
    • Wass M, Göllner S, Besenbeck B, Schlenk RF, Mundmann P, Göthert JR, Noppeney R, Schliemann C, Mikesch JH, Lenz G, Dugas M, Wermke M, Röllig C, Bornhäuser M, Serve H, Platzbecker U, Foerster KI, Burhenne J, Haefeli WE, Müller LP, Binder M, Pabst C, Müller-Tidow C, {Study Alliance Leukemia}. . ‘A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy.’ Leukemia 2020. doi: 10.1038/s41375-020-0892-z.
    • Pereira MP, Zeidler C, Wallengren J, Halvorsen JA, Weisshaar E, Garcovich S, Misery L, Brenaut E, ?avk E, Potekaev N, Lvov A, Bobko S, Szepietowski JC, Reich A, Bozek A, Legat FJ, Metz M, Streit M, Serra-Baldrich E, Gon{çc}}alo M, Storck M, Nau T, Hoffmann V, Steinke S, Greiwe I, Dugas M, Augustin M, Ständer S. . ‘Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.’ Acta dermato-venereologica 2020. doi: 10.2340/00015555-3726.
    • Zeidler C, Pereira MP, Dugas M, Augustin M, Storck M, Weyer-Elberich V, Schneider G, Ständer S. . ‘The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: A comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort.’ Journal of the European Academy of Dermatology and Venereology 2020. doi: 10.1111/jdv.16929.
    • Pauli C, Liu Y, Rohde C, Cui C, Fijalkowska D, Gerloff D, Walter C, Krijgsveld J, Dugas M, Edemir B, Pabst C, Müller LP, Zhou F, Müller-Tidow C. . ‘Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation.’ Blood 135, Nr. 23: 2059-2070. doi: 10.1182/blood.2019004121.
    • Pereira MP, Hoffmann V, Weisshaar E, Wallengren J, Halvorsen JA, Garcovich S, Misery L, Brenaut E, Savk E, Potekaev N, Lvov A, Bobko S, Szepietowski JC, Reich A, Bozek A, Legat FJ, Metz M, Streit M, Serra-Baldrich E, Gon{çc}}alo M, Storck M, Greiwe I, Nau T, Steinke S, Dugas M, Ständer S, Zeidler C, {EPP Consensus Conference Participants 2017}, Dalgard F, Elberling J, Forner C, Leslie T, Riepe C, Schneider G, Ständer H. . ‘Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.’ Journal of the European Academy of Dermatology and Venereology 34, Nr. 10: 2373-2383. doi: 10.1111/jdv.16309.
    • Schuster B, Dugas M, Zink A. . ‘[Medical apps-possibilities for pruritus].’ Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte 71, Nr. 7: 528-534.
    • Sandmann S, Graaf AO, Tobiasson M, Kosmider O, Abáigar M, Clappier E, Gall{\'i} A, {van der Reijden} BA, Malcovati L, Fenaux P, Díez-Campelo M, Fontenay M, Hellström-Lindberg E, Jansen JH, Dugas M. . ‘Multicenter Next-Generation Sequencing Studies Between Theory and Practice: Harmonization of Data Analysis Using Real-World Myelodysplastic Syndrome Data.’ The Journal of molecular diagnostics 2020. doi: 10.1016/j.jmoldx.2020.12.001.
    • Varghese J, Fujarski M, Hahn T, Dugas M, Warnecke T. . ‘The Smart Device System for Movement Disorders: Preliminary Evaluation of Diagnostic Accuracy in a Prospective Study.’ Studies in health technology and informatics 270: 889-893.
    • Wyrwoll MJ, Temel ?, Nagirnaja L, Oud MS, Lopes AM, {van der Heijden} GW, Heald JS, Rotte N, Wistuba J, Wöste M, Ledig S, Krenz H, Smits RM, Carvalho F, Gon{çc}}alves J, Fietz D, Türkgen{çc}} B, Ergören MC, {çC}}etinkaya M, Ba?ar M, Kahraman S, McEleny K, Xavier MJ, Turner H, Pilatz A, Röpke A, Dugas M, Kliesch S, Neuhaus N, {GEMINI Consortium}, Aston KI, Conrad DF, Veltman JA, Friedrich C, Tüttelmann F. . ‘Bi-allelic Mutations in M1AP Are a Frequent Cause of Meiotic Arrest and Severely Impaired Spermatogenesis Leading to Male Infertility.’ American journal of human genetics 107, Nr. 2: 342-351. doi: 10.1016/j.ajhg.2020.06.010.
    • Khanam T, Sandmann S, Seggewiss J, Ruether CM, Zimmermann M, Norvil A, Bartenhagen C, Randau G, Mueller S, Herbrüggen H, Hoffmann P, Herms S, Wei L, Wöste M, Wünsch C, Gowher H, Oschlies I, Klapper W, Woessmann W, Dugas M, Burkhardt B. . ‘Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance.’ Blood 2020. doi: 10.1182/blood.2020005381.
    • Blitz R, Dugas M. . ‘Conceptual Design, Implementation, and Evaluation of Generic and Standard-Compliant Data Transfer into Electronic Health Records.’ Applied clinical informatics 11, Nr. 3: 374-386.
    • Richter MF, Storck M, Blitz R, Goltermann J, Seipp J, Dannlowski U, Baune BT, Dugas M, Opel N. . ‘Repeated Digitized Assessment of Risk and Symptom Profiles During Inpatient Treatment of Affective Disorder: Observational Study.’ JMIR Ment Health 7, Nr. 12: e24066. doi: 10.2196/24066.
    • Bolte FJ, Langenstroer C, Friebel F, Hüsing-Kabar A, Dugas M, Schmidt HH. . ‘Patient-reported outcomes on familial amyloid polyneuropathy (FAP).’ Orphanet journal of rare diseases 15, Nr. 1: 287. doi: 10.1186/s13023-020-01575-6.
    • Dugas M, Schrempf IM, Ochs K, Frömmel C, Greulich L, Neuhaus P, Tepasse PR, Schmidt HH. . ‘Association of contact to small children with a mild course of COVID-19.’ International journal of infectious diseases 100: 314-315. doi: 10.1016/j.ijid.2020.09.003.
    • Holz C, Kessler T, Dugas M, Varghese J. . ‘Core Data Elements in Acute Myeloid Leukemia: A Unified Medical Language System-Based Semantic Analysis and Experts' Review.’ JMIR Med Inf 7, Nr. 3: e13554. doi: 10.2196/13554.
    • Varghese J, Fujarski M, Dugas M. . ‘StudyPortal - Geovisualization of Study Research Networks.’ Journal of medical systems 44, Nr. 1: 22.
    • Rodríguez-Hernández G, Opitz FV, Delgado P, Walter C, Álvarez-Prado ÁF, González-Herrero I, Auer F, Fischer U, Janssen S, Bartenhagen C, Raboso-Gallego J, Casado-García A, Orfao A, Blanco O, Alonso-López D, Rivas JL, Tena-Dávila SG, Müschen M, Dugas M, Criado FJ, Cenador MB, Vicente-Due{ñ}as C, Hauer J, Ramiro AR, Sanchez-Garcia I, Borkhardt A. . ‘Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.’ Nature communications 10, Nr. 1: 5563.
    • Reder H, Wagner S, Gamerdinger U, Sandmann S, Wuerdemann N, Braeuninger A, Dugas M, Gattenloehner S, Klussmann JP, Wittekindt C. . ‘Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.’ Oral oncology 93: 59-65. doi: 10.1016/j.oraloncology.2019.04.013.
    • Brix TJ, Neuhaus P, Storck M, Soto-Rey I, Dugas M. . ‘Reviving 30 Year Old Technology: Lessons Learned from Transferring Patient Data Using Data Matrix Codes.’ Studies in health technology and informatics 258: 90-94.
    • Kentgen M, Varghese J, Samol A, Waltenberger J, Dugas M. . ‘Common Data Elements for Acute Coronary Syndrome: Analysis Based on the Unified Medical Language System.’ JMIR Med Inform 7, Nr. 3: e14107. doi: 10.2196/14107.
    • Dugas M, Hegselmann S, Riepenhausen S, Neuhaus P, Greulich L, Meidt A, Varghese J. . ‘Compatible Data Models at Design Stage of Medical Information Systems: Leveraging Related Data Elements from the MDM Portal.’ Studies in health technology and informatics 264: 113-117.
    • Storck M, Hollenberg L, Dugas M, Soto-Rey I. . ‘Interoperability Improvement of Mobile Patient Survey (MoPat) Implementing Fast Health Interoperability Resources (FHIR).’ Studies in health technology and informatics 258: 141-145.
    • Varghese J, Fujarski M, Dugas M. . ‘StudyPortal - A Novel Method to Visualize Study Research Networks.’ Studies in health technology and informatics 258: 163.
    • Riepenhausen S, Varghese J, Neuhaus P, Storck M, Meidt A, Hegselmann S, Dugas M. . ‘Portal of Medical Data Models: Status 2018.’ Studies in health technology and informatics 258: 239-240.
    • Martial S, Brix TJ, Klotz L, Neuhaus P, Berger K, Warnke C, Meuth SG, Wiendl H, Dugas M. . ‘EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseases.’ PLoS ONE 14, Nr. 10: e0223886.
    • Ropke A, Kockerling N, Wyrwoll MJ, Emich J, Woste M, Dugas M, Pilatz A, Schuppe H, Diemer T, Fietz D, Krallmann C, Kliesch S, Friedrich C, Tuttelmann F. . ‘Genetic analysis of 24 candidate genes validates TEX14, TEX11, NR5A1 and DMRT1 as clinically relevant for non-obstructive azoospermia.’ European journal of human genetics 27 2: 1191.
    • Walter C, Schuetzmann D, Rosenbauer F, Dugas M. . ‘Benchmarking of 4C-seq pipelines based on real and simulated data.’ Bioinformatics 35, Nr. 23.
    • Schipmann S, Varghese J, Brix T, Schwake M, Keurhorst D, Lohmann S, {Suero Molina} E, Mauer UM, Dugas M, Warneke N, Stummer W. . ‘Establishing risk-adjusted quality indicators in surgery using administrative data-an example from neurosurgery.’ Acta neurochirurgica 161, Nr. 6: 1057-1065. doi: 10.1007/s00701-018-03792-2.
    • Varghese J, Niewöhner S, Soto-Rey I, Schipmann-Mileti S, Warneke N, Warnecke T, Dugas M. . ‘A Smart Device System to Identify New Phenotypical Characteristics in Movement Disorders.’ Frontiers in neurology 10: 48. doi: 10.3389/fneur.2019.00048.
    • Fischer J, Walter C, Tönges A, Aleth H, Jordão MJC, Leddin M, Gröning V, Erdmann T, Lenz G, Roth J, Vogl T, Prinz M, Dugas M, Jacobsen ID, Rosenbauer F. . ‘Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils.’ Nature Immunology Mar 25.
    • Schipmann S, Brix T, Varghese J, Warneke N, Schwake M, Brokinkel B, Ewelt C, Dugas M, Stummer W. . ‘Adverse events in brain tumor surgery: incidence, type, and impact on current quality metrics.’ Acta neurochirurgica 161, Nr. 2: 287-306. doi: 10.1007/s00701-018-03790-4.
    • Wünsch C, Dugas M.REST-based annotation and filtering of Next-Generation Sequencing variant lists with integration into standard office tools.“ contributed to the European Conference on Computational Biology (ECCB), Athen, . doi: 10.7490/f1000research.1116119.1.
    • Ruther C, Khanam T, Bartenhagen C, Seggewiss J, Herbruggen H, Muller S, Wunsch C, Oschlies I, Klapper W, Dugas M, Sandmann S, Burkhardt B. . ‘Targeted panel for pediatric T-LBL.’ British journal of haematology 182 1: 52.
    • Varghese J, Sandmann S, Dugas M. . ‘Web-Based Information Infrastructure Increases the Interrater Reliability of Medical Coders: Quasi-Experimental Study.’ Journal of medical Internet research 20, Nr. 10: e274.
    • Brozou T, Taeubner J, Velleuer E, Dugas M, Wieczorek D, Borkhardt A, Kuhlen M. . ‘Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.Y - 2018.’ European journal of pediatrics 177, Nr. 1: 53-60.
    • Schipmann S, Brix T, Varghese J, Warneke N, Schwake M, Brokinkel B, Ewelt C, Dugas M, Stummer W. . ‘ADVERSE EVENTS IN BRAIN TUMOR SURGERY: INCIDENCE, TYPE AND IMPACT ON CURRENT QUALITY METRICS.’ Neuro-oncology 20 6: 120. doi: 10.1093/neuonc/noy148.502.
    • Kock-Schoppenhauer AK, Ulrich H, Wagen-Zink S, Duhm-Harbeck P, Ingenerf J, Neuhaus P, Dugas M, Bruland P. . ‘Compatibility Between Metadata Standards: Import Pipeline of CDISC ODM to the Samply.MDR.’ Studies in health technology and informatics 247: 221-225.
    • Reutter K, Rohde J, Khanam T, Herbruggen H, Muller S, Wossmann W, Oschlies I, Klapper W, Dugas M, Sandmann S, Burkhardt B. . ‘The mutational spectrum of relapsed Burkitt lymphoma in children and adolescents.’ British journal of haematology 182 1, Nr. SI: 80.
    • Brozou T, Taeubner J, Velleuer E, Dugas M, Wieczorek D, Borkhardt A, Kuhlen M. . ‘Correction to: Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.’ European journal of pediatrics 177, Nr. 1: 61.
    • Varghese J, Fujarski M, Hegselmann S, Neuhaus P, Dugas M. . ‘CDEGenerator: an online platform to learn from existing data models to build model registries.’ Clinical epidemiology 10: 961-970. doi: 10.2147/CLEP.S170075.
    • Martín-Lorenzo A, Auer F, Chan LN, García-Ramírez I, González-Herrero I, Rodríguez-Hernández G, Bartenhagen C, Dugas M, Gombert M, Ginzel S, Blanco O, Orfao A, Alonso-López D, Rivas JL, García-Cenador MB, García-Criado FJ, Müschen M, Sánchez-García I, Borkhardt A, Vicente-Due{ñ}as C, Hauer J. . ‘Loss of Pax5 Exploits Sca1-BCR-ABL Susceptibility to Confer the Metabolic Shift Essential for pB-ALL.’ Cancer research 78, Nr. 10: 2669-2679.
    • García-Ramírez I, Bhatia S, Rodríguez-Hernández G, González-Herrero I, Walter C, {González de Tena-Dávila}}} S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A, Domínguez V, Pintado B, Blanco O, Alonso-López D, {Las Rivas} J, Martín-Lorenzo A, Jiménez R, {García Criado}} FJ, {García Cenador}} MB, Lossos IS, Vicente-Due{ñ}as C, Borkhardt A, Hauer J, Sánchez-García I. . ‘Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.’ The EMBO journal 37, Nr. 14.
    • Hegselmann S, Storck M, Ge{ß}ner S, Neuhaus P, Varghese J, Dugas M. . ‘A Web Service to Suggest Semantic Codes Based on the MDM-Portal.’ Studies in health technology and informatics 253: 35-39.
    • Schuetzmann D, Walter C, {van Riel} B, Kruse S, König T, Erdmann T, Tönges A, Bindels E, Weilemann A, Gebhard C, Wethmar K, Perrod C, Minderjahn J, Rehli M, Delwel R, Lenz G, Gröschel S, Dugas M, Rosenbauer F. . ‘Temporal autoregulation during human PU.1 locus SubTAD formation.’ Blood 132, Nr. 25: 2643-2655. doi: 10.1182/blood-2018-02-834721.
    • Agelopoulos K, Lotts T, Conrad H, Dugas M, Stander S. . ‘Gene expression profiling in chronic prurigo of nodular type.’ Experimental dermatology 27, Nr. 3: E79-E80.
    • Bruland P, Doods J, Brix T, Dugas M, Storck M. . ‘Connecting healthcare and clinical research: Workflow optimizations through seamless integration of EHR, pseudonymization services and EDC systems.’ International journal of medical informatics 119: 103-108. doi: 10.1016/j.ijmedinf.2018.09.007.
    • Brozou T, Taeubner J, Velleuer E, Dugas M, Wieczorek D, Borkhardt A, Kuhlen M. . ‘Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.’ European journal of pediatrics 177, Nr. 1: 53-60.
    • Brozou T, Taeubner J, Velleuer E, Dugas M, Wieczorek D, Borkhardt A, Kuhlen M. . ‘Correction to: Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.Y - 2018.’ European journal of pediatrics 177, Nr. 1: 61-.
    • Khanam T, Ruther C, Bartenhagen C, Seggewiss J, Herbruggen H, Muller S, Wunsch C, Oschlies I, Klapper W, Dugas M, Sandmann S, Burkhardt B. . ‘Mutational spectrum of relapse in pediatric and adolescent patients with T-LBL.’ British journal of haematology 182 1: 20.
    • Soto-Rey I, Neuhaus P, Bruland P, Ge{ß}ner S, Varghese J, Hegselmann S, Brix T, Dugas M, Storck M. . ‘Standardising the Development of ODM Converters: The ODMToolBox.’ Studies in health technology and informatics 247: 231-235.
    • Schuetzmann D, Walter C, van Riel B, Kruse S, König T, Erdmann T, Tönges A, Bindels E, Weilemann A, Gebhard C, Wethmar K, Perrod C, Minderjahn J, Rehli M, Delwel R, Lenz G, Gröschel S, Dugas M, Rosenbauer F. . ‘Temporal auto-regulation during human PU.1 locus SubTAD formation.’ Blood 132.
    • Wünsch C, Sandmann S, Windau S, Dugas M.AML-Varan – a generic approach to integrate a multi-tool-combination based NGS variant calling pipeline into a web-based diagnostics platform.“ contributed to the Intelligent Systems for Molecular Biology (ISMB), Prag, . doi: 10.7490/f1000research.1114839.1.
    • Hegselmann S, Gessner S, Neuhaus P, Henke J, Schmidt C, Dugas M. . ‘Automatic Conversion of Metadata from the Study of Health in Pomerania to ODM.Studies in health technology and informatics 236: 88-96.
    • Gessner S, Storck M, Hegselmann S, Dugas M, Soto-Rey I. . ‘Automated Transformation of CDISC ODM to OpenClinica.Studies in health technology and informatics 243: 95-99.
    • Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz M, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe H, Ganser A, Stocking C, Fehse B, Thol F, Heuser M. . ‘Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23, Nr. 7: 1095-1101.
    • Sandmann S, Karimi M, de Graaf A, van der Reijden B, Hellstrom-Lindberg E, Jansen J, Dugas M. . ‘APPRECI8: A PIPELINE FOR PRECISE VARIANT CALLING INTEGRATING 8 TOOLS.’ Haematologica 102 2: 492-492.
    • Zeidler C, Bruland P, Riepe C, Soto Rey I, Steinke S, Storck M, Dugas M, Stander S. . ‘Initiative PruNet: Validation of Instruments for the Measurement of Pruritus Intensity and Quality of Life in itchy Dermatoses in Europe.’ Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German 15: 186-187.
    • Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, Köhn M, Misiak D, Bäumer N, Cui C, Göllner S, Oellerich T, Serve H, Garcia-Cuellar M, Slany R, Maciejewski J, Przychodzen B, Seliger B, Klein H, Bartenhagen C, Berdel W, Dugas M, Taketo M, Farouq D, Schwartz S, Regev A, Hébert J, Sauvageau G, Pabst C, Hüttelmaier S, Müller-Tidow C. . ‘AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.Nature cell biology 19, Nr. 7: 844-855.
    • Storck M, Wohlmann J, Krudwig S, Vogel A, Born J, Weber T, Dugas M, Juhra C. . ‘A Secure Architecture to Provide a Medical Emergency Dataset for Patients in Germany and Abroad.Studies in health technology and informatics 245: 230-234.
    • Bruland P, Doods J, Storck M, Dugas M. . ‘What Information Does Your EHR Contain? Automatic Generation of a Clinical Metadata Warehouse (CMDW) to Support Identification and Data Access Within Distributed Clinical Research Networks.Studies in health technology and informatics 245: 313-317.
    • Bruland P, Kathöfer U, Treder M, Eter N, Dugas M. . ‘Integrating x4T-EDC into an Image-Portal to Establish an Ophthalmic Reading Center.Studies in health technology and informatics 245: 1254-.
    • Varghese J, Kleine M, Gessner S, Sandmann S, Dugas M. . ‘Medical Effect of Venous Thromboembolism Prophylaxis Systems and Common Input Categories: Preliminary Findings from a Systematic Review.Studies in health technology and informatics 245: 1175-1179.
    • Brozou T, Kuhlen M, Borkhardt A, Fremerey J, Velleuer E, Wieczorek D, Gombert M, Walter C, Dugas M. . ‘Cancer Predisposition in Childhood Cancer -The Duesseldorf Experience in Comprehensive Clinical Evaluation and Trio Whole Exome Sequencing of Families.’ Pediatric blood & cancer 64 3: S154-S155.
    • Geßner S, Neuhaus P, Varghese J, Bruland P, Meidt A, Soto-Rey I, Storck M, Doods J, Dugas M. . ‘The Portal of Medical Data Models: Where Have We Been and Where Are We Going?Studies in health technology and informatics 245: 858-862.
    • Soto-Rey I, Geßner S, Dugas M. . ‘Operational Data Model Conversion to ResearchKit.Studies in health technology and informatics 245: 225-229.
    • da Silva-Coelho P, Kroeze L, Yoshida K, Koorenhof-Scheele T, Knops R, van de Locht L, de Graaf A, Massop M, Sandmann S, Dugas M, Stevens-Kroef M, Cermak J, Shiraishi Y, Chiba K, Tanaka H, Miyano S, de Witte T, Blijlevens N, Muus P, Huls G, van der Reijden B, Ogawa S, Jansen J. . ‘Clonal evolution in myelodysplastic syndromes.Nature communications 8: 15099-.
    • Varghese J, Kleine M, Gessner S, Sandmann S, Dugas M. . ‘Effects of computerized decision support system implementations on patient outcomes in inpatient care: a systematic review.Journal of the American Medical Informatics Association 2017.
    • Zeidler C, Bruland P, Riepe C, Soto I, Steinke S, Storck M, Dugas M, Stander S. . ‘EUROPEAN EADV NETWORK ON ASSESSMENT OF SEVERITY AND BURDEN OF PRURITUS (PRUNET): VALIDATION OF INSTRUMENTS FOR ITCH INTENSITY ITCH-IMPAIRED QUALITY OF LIFE IN PRURITIC DERMATOSES IN EUROPE.’ Acta dermato-venereologica 97, Nr. 8: 1025-1025.
    • Rodríguez-Hernández G, Hauer J, Martín-Lorenzo A, Schäfer D, Bartenhagen C, García-Ramírez I, Auer F, González-Herrero I, Ruiz-Roca L, Gombert M, Okpanyi V, Fischer U, Chen C, Dugas M, Bhatia S, Linka R, Garcia-Suquia M, Rascón-Trincado M, Garcia-Sanchez A, Blanco O, García-Cenador M, García-Criado F, Cobaleda C, Alonso-López D, De Las Rivas J, Müschen M, Vicente-Dueñas C, Sánchez-García I, Borkhardt A. . ‘Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases.Cancer research 77, Nr. 16: 4365-4377.
    • Zeidler C, Bruland P, Riepe C, Soto I, Steinke S, Storck M, Dugas M, Stander S. . ‘EUROPEAN EADV NETWORK ON ASSESSMENT OF SEVERITY AND BURDEN OF PRURITUS (PRUNET): VALIDATION OF INSTRUMENTS FOR ITCH INTENSITY ITCH-IMPAIRED QUALITY OF LIFE IN PRURITIC DERMATOSES IN EUROPE.’ Acta dermato-venereologica 97, Nr. 8: 1025-1025.
    • Göllner S, Oellerich T, Agrawal-Singh S, Schenk T, Klein H, Rohde C, Pabst C, Sauer T, Lerdrup M, Tavor S, Stölzel F, Herold S, Ehninger G, Köhler G, Pan K, Urlaub H, Serve H, Dugas M, Spiekermann K, Vick B, Jeremias I, Berdel W, Hansen K, Zelent A, Wickenhauser C, Müller L, Thiede C, Müller-Tidow C. . ‘Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.Nature medicine 23, Nr. 1: 69-78.
    • Girardeau Y, Doods J, Zapletal E, Chatellier G, Daniel C, Burgun A, Dugas M, Rance B. . ‘Leveraging the EHR4CR platform to support patient inclusion in academic studies: challenges and lessons learned.BMC medical research methodology 17, Nr. 1: 36-.
    • Storck M, Dugas-Breit S, Dugas M, Soto-Rey I. . ‘MOPAT@HOME: Electronic Patient Reported Outcomes Filled Out at Home, Evaluated at the Hospital.Studies in health technology and informatics 244: 101-.
    • Agelopoulos K, Lotts T, Conrad H, Dugas M, Stander S. . ‘GLOBAL GENE EXPRESSION PROFILING IN PRURIGO NODULARIS.’ Acta dermato-venereologica 97, Nr. 8: 1037-1037.
    • Bartenhagen C, Fischer U, Korn K, Pfister S, Gombert M, Chen C, Okpanyi V, Hauer J, Rinaldi A, Bourquin J, Eckert C, Hu J, Ensser A, Dugas M, Borkhardt A. . ‘Infection as a cause of childhood leukemia: virus detection employing whole genome sequencing.Haematologica 102, Nr. 5: e179-e183.
    • Bruland P, Kathöfer U, Treder M, Eter N, Dugas M. . ‘Integrating x4T-EDC into an Image-Portal to Establish an Ophthalmic Reading Center.’ Stud Health Technol Inform 245: 1254.
    • Sandmann S., De Graaf A., Van Der Reijden B., Jansen J., Dugas M. . ‘GLM-based optimization of NGS data analysis: A case study of Roche 454, ion torrent PGM and Illumina NextSeq sequencing data.’ PLoS ONE 12, Nr. 2. doi: 10.1371/journal.pone.0171983.
    • Steinke S., Bruland P., Blome C., Osada N., Dugas M., Fritz F., Augustin M., Ständer S. . ‘Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex.’ British Journal of Dermatology 176, Nr. 2: 363-370. doi: 10.1111/bjd.14910.
    • Pereira MP, Steinke S, Zeidler C, Forner C, Riepe C, Augustin M, Bobko S, Dalgard F, Elberling J, Garcovich S, Gieler U, Gonçalo M, Halvorsen JA, Leslie TA, Metz M, Reich A, Şavk E, Schneider G, Serra-Baldrich E, Ständer HF, Streit M, Wallengren J, Weller K, Wollenberg A, Bruland P, Soto-Rey I, Storck M, Dugas M, Weisshaar E, Szepietowski JC, Legat FJ, Ständer S; EADV Task Force Pruritus group members. . ‘European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.’ Journal of the European Academy of Dermatology and Venereology n/a. doi: 10.1111/jdv.14570.
    • Bruland P., Dugas M. . ‘S2O - A software tool for integrating research data from general purpose statistic software into electronic data capture systems.’ BMC Medical Informatics and Decision Making 17, Nr. 1. doi: 10.1186/s12911-016-0402-4.
    • Sandmann S, de Graaf AO, Dugas M. . ‘BBCAnalyzer: a visual approach to facilitate variant calling.’ BMC Bioinformatics 18. doi: 10.1186/s12859-017-1549-4.
    • Sandmann S., De Graaf A., Karimi M., Van Der Reijden B., Hellström-Lindberg E., Jansen J., Dugas M. . ‘Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data.’ Scientific Reports 7, Nr. null. doi: 10.1038/srep43169.
    • Wünsch C, Banck H, Stenner J, Dugas M.AML-Varan - a web-based platform to display and analyze genomic variants from targeted NGS sequencing data.“ contributed to the European Conference on Computational Biology (ECCB), Den Haag, . doi: 10.7490/f1000research.1113145.1.
    • Soto-Rey I, Dugas M, Storck M. . ‘Implementation of an ODM and HL7 Compliant Electronic Patient-Reported Outcome System.Studies in health technology and informatics 228: 421-5.
    • Dugas M, Meidt A, Neuhaus P, Storck M, Varghese J. . ‘ODMedit: uniform semantic annotation for data integration in medicine based on a public metadata repository.BMC medical research methodology 16: 65-.
    • Dugas M. . ‘Sharing clinical trial data.Lancet 387, Nr. 10035: 2287-.
    • Gollner S, Agrawal-Singh S, Oellerich T, Schenk T, Rohde C, Klein H, Sauer T, Lerdrup M, Tavor S, Stolzel F, Ehninger G, Kohler G, Pan K, Urlaub H, Serve H, Dugas M, Berdel W, Hansen K, Zelent A, Thiede C, Muller-Tidow C. . ‘A NOVEL EPIGENETIC RESISTANCE MECHANISM TO THE FLT3 INHIBITOR PKC412 INDUCES CROSS-RESISTANCE TO STANDARD CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA (AML).’ Haematologica 101 1: 166-166.
    • Varghese J, Holz C, Neuhaus P, Bernardi M, Boehm A, Ganser A, Gore S, Heaney M, Hochhaus A, Hofmann W, Krug U, Müller-Tidow C, Smith A, Weltermann A, de Witte T, Hehlmann R, Dugas M. . ‘Key Data Elements in Myeloid Leukemia.Studies in health technology and informatics 228: 282-6.
    • Dugas M. . ‘Design of case report forms based on a public metadata registry: re-use of data elements to improve compatibility of data.Trials 17, Nr. 1: 566-.
    • Storck M, Krumm R, Dugas M. . ‘ODMSummary: A Tool for Automatic Structured Comparison of Multiple Medical Forms Based on Semantic Annotation with the Unified Medical Language System.PLoS ONE 11, Nr. 10: e0164569-.
    • Müller-Tidow C., Tschanter P., Röllig C., Thiede C., Koschmieder A., Stelljes M., Koschmieder S., Dugas M., Gerss J., Butterfaß-Bahloul T., Wagner R., Eveslage M., Thiem U., Krause S., Kaiser U., Kunzmann V., Steffen B., Noppeney R., Herr W., Baldus C., Schmitz N., Götze K., Reichle A., Kaufmann M., Neubauer A., Schäfer-Eckart K., Hänel M., Peceny R., Frickhofen N., Kiehl M., Giagounidis A., Görner M., Repp R., Link H., Kiani A., Naumann R., Brümmendorf T., Serve H., Ehninger G., Berdel W., Krug U. . ‘Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia.’ Leukemia 30, Nr. 3: 555-561. doi: 10.1038/leu.2015.306.
    • Ständer S, Zeidler C, Riepe C, Steinke S, Fritz F, Bruland P, Soto-Rey I, Storck M, Agner T, Augustin M, Blome C, Dalgard F, Evers AW, Garcovich S, Gonçalo M, Lambert J, Legat FJ, Leslie T, Misery L, Raap U, Reich A, Şavk E, Streit M, Serra-Baldrich E, Szepietowski J, Wallengren J, Weisshaar E, Dugas M. . ‘European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools.’ Journal of the European Academy of Dermatology and Venereology 30, Nr. 7: 1144-1147. doi: 10.1111/jdv.13296.
    • Dugas M., Neuhaus P., Meidt A., Doods J., Storck M., Bruland P., Varghese J. . ‘Portal of medical data models: Information infrastructure for medical research and healthcare.’ Database 2016, Nr. null. doi: 10.1093/database/bav121.
    • Ständer S, Ständer H, Steinke S, Bruland P, Dugas M, Augustin M. . „Chronic pruritus : Care in daily practice.“ Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte 67, Nr. 8: 640-7.
    • Kossak-Roth U, Saussele S, Aul C, Buchner T, Dohner H, Dugas M, Ehninger G, Ganser A, Giagounidis A, Gokbuget N, Griesshammer M, Hasford J, Heuser M, Hiddemann W, Hochhaus A, Hoelzer D, Niederwieser D, Reiter A, Rollig C, Hehlmann R. . ‘Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias.’ Bundesgesundheitsblatt Gesundheitsforschung, Gesundheitsschutz 59, Nr. 4: 444-453.
    • Bartenhagen C, Dugas M. . ‘Robust and exact structural variation detection with paired-end and soft-clipped alignments: SoftSV compared with eight algorithms.Briefings in bioinformatics 17, Nr. 1: 51-62.
    • Bruland P., McGilchrist M., Zapletal E., Acosta D., Proeve J., Askin S., Ganslandt T., Doods J., Dugas M. . ‘Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting.’ BMC Medical Research Methodology 16, Nr. 1. doi: 10.1186/s12874-016-0259-3.
    • Garcia-Cuellar M, Büttner C, Bartenhagen C, Dugas M, Slany R. . ‘Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes.Cell reports 15, Nr. 2: 310-22.
    • Schulze I., Rohde C., Scheller-Wendorff M., Bäumer N., Krause A., Herbst F., Riemke P., Hebestreit K., Tschanter P., Lin Q., Linhart H., Godley L., Glimm H., Dugas M., Wagner W., Berdel W., Rosenbauer F., Müller-Tidow C. . ‘Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.’ Blood 127, Nr. 12: 1575-1586. doi: 10.1182/blood-2015-07-655928.
    • Doods J, Neuhaus P, Dugas M. . ‘Converting ODM Metadata to FHIR Questionnaire Resources.Studies in health technology and informatics 228: 456-60.
    • Riemke P., Czeh M., Fischer J., Walter C., Ghani S., Zepper M., Agelopoulos K., Lettermann S., Gebhardt M., Mah N., Weilemann A., Grau M., Gröning V., Haferlach T., Lenze D., Delwel R., Prinz M., Andrade-Navarro M., Lenz G., Dugas M., Müller-Tidow C., Rosenbauer F. . ‘Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.’ EMBO Journal 35, Nr. 22: 2399-2416. doi: 10.15252/embj.201693927.
    • Warlich B., Fritz F., Bruland P., Stumpf A., Schneider G., Dugas M., Pfleiderer B., Ständer S. . ‘Health-Related Quality of Life in Chronic Pruritus: An Analysis Related to Disease Etiology, Clinical Skin Conditions and Itch Intensity.Dermatology 231: 253-259.
    • Soto-Rey I., Trinczek B., Girardeau Y., Zapletal E., Ammour N., Doods J., Dugas M., Fritz F. . ‘Efficiency and effectiveness evaluation of an automated multi-country patient count cohort system study design.’ BMC Medical Research Methodology 15, Nr. 1. doi: 10.1186/s12874-015-0035-9.
    • Walter C, Schuetzmann D, Rosenbauer F, Dugas M. . ‘Basic4Cseq: an R/Bioconductor package for analyzing 4C-seq data.’ Bioinformatics 30, Nr. 22: 3268-3269. doi: 10.1093/bioinformatics/btu497.
    • Heuser M., Schlarmann C., Dobbernack V., Panagiota V., Wiehlmann L., Walter C., Beier F., Ziegler P., Yun H., Kade S., Kirchner A., Huang L., Koenecke C., Eder M., Brümmendorf T., Dugas M., Ganser A., Thol F. . ‘Genetic characterization of acquired aplastic anemia by targeted sequencing.’ Haematologica 99, Nr. 9. doi: 10.3324/haematol.2013.101642.
    • Thol F., Bollin R., Gehlhaar M., Walter C., Dugas M., Suchanek K., Kirchner A., Huang L., Chaturvedi A., Wichmann M., Wiehlmann L., Shahswar R., Damm F., Göhring G., Schlegelberger B., Schlenk R., Döhner K., Döhner H., Krauter J., Ganser A., Heuser M. . ‘Mutations in the cohesin complex in acute myeloid leukemia: Clinical and prognostic implications.’ Blood 123, Nr. 6: 914-920. doi: 10.1182/blood-2013-07-518746.
    • Bruland P., Dugas M. . ‘Transformations between CDISC ODM and openEHR Archetypes.’ Contributed to the 25th European Medical Informatics Conference, MIE 2014, tur. doi: 10.3233/978-1-61499-432-9-1225.
    • Schoofs T, Rohde C, Hebestreit K, Klein HU, Göllner S, Schulze I, Lerdrup M, Dietrich N, Agrawal-Singh S, Witten A, Stoll M, Lengfelder E, Hofmann WK, Schlenke P, Büchner T, Hansen K, Berdel WE, Rosenbauer F, Dugas M, Müller-Tidow C. . ‘DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.Blood 121, Nr. 1: 178-87.
    • Lahti L, Schäfer M, Klein HU, Bicciato S, Dugas M. . ‘Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: a comparative review.Brief Bioinform 14, Nr. 1: 27-35.
    • Staender S, Dugas M, Fritz F, Heindel W, Heuft G, Marziniak M, Pavenstaedt H, Pfleiderer B, Pogatzki-Zahn E, Schneider G, Suwelack B, Aken H, Wessling J, Wiendl H, Luger TA. . ‘COMPETENCE CENTER CHRONIC PRURITUS AT THE UNIVERSITY HOSPITAL OF MUNSTER: A DEDICATED CENTER WITH A DECADE OF EXPERIENCE IN MULTIDISCIPLINARY MEDICAL CARE.’ ACTA DERMATO-VENEREOLOGICA 93, Nr. 5: 634.
    • Fritz F, Riek M, Breil B, Dugas M, Stander S. . ‘Mobile Capture of the DLQI (Dermatology Life Quality Index) for medical Care and Research in Dermatology.’ Exp Dermatol 21, Nr. 3: e49-e49.
    • Fritz F, Balhorn S, Riek M, Breil B, Dugas M. . ‘Qualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency.Int J Med Inform 81, Nr. 5: 303-13. doi: 10.1016/j.ijmedinf.2011.12.008.
    • Schenk T, Chen WC, Göllner S, Howell L, Jin L, Hebestreit K, Klein HU, Popescu AC, Burnett A, Mills K, Casero RA, Marton L, Woster P, Minden MD, Dugas M, Wang JC, Dick JE, Müller-Tidow C, Petrie K, Zelent A. . ‘Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.Nat Med 18, Nr. 4: 605-11.
    • Wildenhain S, Ingenhag D, Ruckert C, Degistirici Ö, Dugas M, Meisel R, Hauer J, Borkhardt A. . ‘Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.J Biol Chem 287, Nr. 48: 40703-12.
    • Fischer U, Ruckert C, Hubner B, Eckermann O, Binder V, Bakchoul T, Schuster FR, Merk S, Klein HU, Führer M, Dugas M, Borkhardt A. . ‘CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL.Haematologica 97, Nr. 9: 1304-11.
    • Ständer S, Blome C, Breil B, Bruland P, Darsow U, Dugas M, Evers A, Fritz F, Metz M, Phan NQ, Raap U, Reich A, Schneider G, Steinke S, Szepietowski J, Weisshaar E, Augustin M. . „Assessment of pruritus - current standards and implications for clinical practice : Consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP).“ Hautarzt 63, Nr. 7: 521-31.
    • Ghosh S, Bartenhagen C, Okpanyi V, Gombert M, Binder V, Teigler-Schlegel A, Bradtke J, Rottgers S, Dugas M, Borkhardt A. . ‘Next-generation sequencing reveals complex molecular rearrangements in MLLT10/MLL childhood AML.’ Eur J Pediatr 171, Nr. 9: 1426-1426.
    • Bruland P, Breil B, Fritz F, Dugas M. . ‘Interoperability in clinical research: from metadata registries to semantically annotated CDISC ODM.Stud Health Technol Inform 180: 564-8. doi: 10.3233/978-1-61499-101-4-564.
    • Breil B, Kenneweg J, Fritz F, Bruland P, Doods D, Trinczek B, Dugas M. . ‘Multilingual medical data models in ODM format--a novel form-based approach to semantic interoperability between routine health-care and clinical research.’ Appl Clin Inf 3: 276--289. doi: 10.4338/ACI-2012-03-RA-0011.
    • Grossmann V, Schnittger S, Schindela S, Klein HU, Eder C, Dugas M, Kern W, Haferlach T, Haferlach C, Kohlmann A. . ‘Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technology.’ J Mol Diagn 13, Nr. 2: 129-136.
    • Grossmann V, Kohlmann A, Klein HU, Schindela S, Schnittger S, Dicker F, Dugas M, Kern W, Haferlach T, Haferlach C. . ‘Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure.Leukemia 25, Nr. 4: 671-680.
    • Dziuballe Philipp, Forster Christian, Breil Bernhard, Thiemann Volker, Fritz Fleur, Lechtenbörger Jens, Vossen Gottfried, Dugas Martin. . ‘The Single Source Architecture x4T to Connect Medical Documentation and Clinical Research.’ In User Centred Networked Health Care - Proceedings of MIE 2011, edited by Moen Anne, Andersen Stig Kjær, Aarts Jos, Hurlen Petter, 902-906.: IOS Press. doi: 10.3233/978-1-60750-806-9-902.
    • Bacher U, Kern W, Alpermann T, Schnittger S, Kohlmann A, Klein HU, Dugas M, Haferlach C, Haferlach T. . ‘Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.’ Leukemia 25, Nr. 8: 1361-1364.
    • Schweer C, Doering S, Haier J, Heuft G, Fritz F, Dugas M, Schneider G. . „[Psychooncological interventions - what do cancer patients aged 60 years or older wish for?].Z Psychosom Med Psychother 57, Nr. 3: 223-32.
    • Breil B, Semjonow A, Müller-Tidow C, Fritz F, Dugas M. . ‘HIS-based Kaplan-Meier plots--a single source approach for documenting and reusing routine survival information.BMC Med Inform Decis Mak 11: 11. doi: 10.1186/1472-6947-11-11.
    • Fritz F, Ständer S, Breil B, Riek M, Dugas M. . ‘CIS-based registration of quality of life in a single source approach.BMC Med Inform Decis Mak 11: 26. doi: 10.1186/1472-6947-11-26.
    • Fritz F, Phan NQ, Riek M, Breil B, Augustin M, Dugas M, Stander S. . ‘MEDICAL CARE OF CHRONIC PRURITUS PATIENTS: HOW TO EFFICIENTLY COLLECT PATIENT REPORTED OUTCOMES.’ Acta Derm Venereol 91, Nr. 5: 636-636.
    • Fritz F, Phan NQ, Dugas M, Augustin M, Stander S. . ‘CORRELATION OF ITCH INTENSITY WITH QUALITY OF LIFE, ANXIETY AND DEPRESSION.’ Acta Derm Venereol 91, Nr. 5: 636-637.
    • Schneider G, Schweer C, Doering S, Haier J, Heuft G, Fritz F, Dugas M. . ‘Psychooncological interventions -what do cancer patients aged 60 years or older wish for?J Psychosom Res 70, Nr. 6: 612-613.
    • Herzberg S, Rahbar K, Stegger L, Schäfers M, Dugas M. . ‘Concept and implementation of a computer-based reminder system to increase completeness in clinical documentation.Int J Med Inform 80, Nr. 5: 351-8.
    • Klein HU, Bartenhagen C, Kohlmann A, Grossmann V, Ruckert C, Haferlach T, Dugas M. . ‘R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing data.’ Bioinformatics 27, Nr. 8: 1162-1163.
    • Breil B, Fritz F, Thiemann V, Dugas M. . ‘Mapping turnaround times (TAT) to a generic timeline: a systematic review of TAT definitions in clinical domains.BMC Med Inform Decis Mak 11: 34. doi: 10.1186/1472-6947-11-34.
    • Chen C, Bartenhagen C, Gombert M, Okpanyi V, Binder V, Roettgers S, Bradtke J, Teigler-Schlegel A, Fischer U, Harbott J, Hu JD, Dugas M, Borkhardt A. . ‘Somatic Structural Variations in Pediatric High Hyperdiploid Acute Lymphoblastic Leukemia Revealed by Paired-End Parallel Sequencing.’ Blood 118, Nr. 21: 184-184.
    • Mate S, Bürkle T, Köpcke F, Breil B, Wullich B, Dugas M, Prokosch HU, Ganslandt T. . ‘Populating the i2b2 database with heterogeneous EMR data: a semantic network approach.Stud Health Technol Inform 169: 502-6.
    • Tickenbrock L, Klein HU, Trento C, Hascher A, Göllner S, Bäumer N, Kuss R, Agrawal S, Bug G, Serve H, Thiede C, Ehninger G, Stadt UZ, McClelland M, Wang Y, Becker A, Koschmieder S, Berdel WE, Dugas M, Müller-Tidow C, for the SAL (Study Alliance Leukemia) Group. . ‘Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.’ Leukemia Research 35, Nr. 5: 620-625. doi: 10.1016/j.leukres.2010.11.006.
    • Binder V, Bartenhagen C, Okpanyi V, Behrens B, Moehlendick B, Klein HU, Rieder H, Gombert M, Dugas M, Stoecklein NH, Borkhardt A. . ‘Whole Genome Amplification with Subsequent High Throughput Sequencing Allows Comprehensive Genome-Wide Analysis of Single Leukemic Cells.’ Blood 118, Nr. 21: 624-624.
    • Dziuballe P, Herzberg S, Breil B, Fritz F, Dugas M. . „Single-Source-Ansätze am Universitätsklinikum Münster.“ mdi 2010, Nr. 2: 57-59.
    • Dugas M, Lange M, Müller-Tidow C, Kirchhof P, Prokosch HU. . ‘Using routine data from hospital information systems to facilitate recruitment in clinical research.Clinical Trials 7, Nr. 2: 183-189.
    • Dugas-Breit S, Przybilla B, Dugas M, Arnold A, Pfundstein G, Küchenhoff H, Ruëff F. . ‘Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.’ Clin Exp Allergy .
    • Müller-Tidow C, Klein HU, Hascher A, Isken F, Tickenbrock L, Thoennissen N, Agrawal-Singh S, Tschanter P, Disselhoff C, Wang Y, Becker A, Thiede C, Ehninger G, Zur Stadt U, Koschmieder S, Seidl M, Müller FU, Schmitz W, Schlenke P, McClelland M, Berdel WE, Dugas M, Serve H. . ‘Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.Blood 116: 3564-71. doi: 10.1182/blood-2009-09-240978.
    • Hömme C, Krug U, Tidow N, Schulte B, Kühler G, Serve H, Bürger H, Berdel WE, Dugas M, Heinecke A, Büchner T, Koschmieder S, Müller-Tidow C. . ‘Low SMC1A protein expression predicts poor survival in acute myeloid leukemia.Oncol Rep 24, Nr. 1: 47-56.
    • Okamoto R, Ogawa S, Nowak D, Kawamata N, Akagi T, Kato M, Sanada M, Weiss T, Haferlach C, Dugas M, Ruckert C, Haferlach T, Koeffler HP. . ‘Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.’ Haematologica 95, Nr. 9.
    • Herzberg S, Rahbar K, Stegger L, Schäfers M, Dugas M. . ‘Concept and implementation of a single source information system in nuclear medicine for myocardial scintigraphy (SPECT-CT data).’ Applied Clinical Informatics 2010, Nr. 1: 50-67. doi: 10.4338/ACI-2009-12-RA-0017.
    • Fritz F, Ständer S, Breil B, Dugas M. . ‘Steps towards single source--collecting data about quality of life within clinical information systems.Stud Health Technol Inform 160, Nr. Pt 1: 188-92.
    • Kohlmann A, Bullinger L, Thiede C, Schaich M, Schnittger S, Döhner K, Dugas M, Klein HU, Döhner H, Ehninger G, Haferlach T. . ‘Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.’ Leukemia 24, Nr. 6: 1216-1220. doi: 10.1038/leu.2010.73.
    • Breil B, Fritz F, Thiemann V, Dugas M. . ‘Multidisciplinary education in medical informatics--a course for medical and informatics students.Stud Health Technol Inform 160, Nr. Pt 1: 581-4.
    • Okamoto R, Ogawa S, Nowak D, Kawamata N, Akagi T, Kato M, Sanada M, Weiss T, Haferlach C, Dugas M, Ruckert C, Haferlach T, Koeffler HP. . ‘Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.Haematologica 95, Nr. 9: 1481-8. doi: 10.3324/haematol.2009.011114.
    • Eminaga O, Hinkelammert R, Semjonow A, Neumann J, Abbas M, Koepke T, Bettendorf O, Eltze E, Dugas M. . ‘Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.BMC Med Inform Decis Mak 10: 71. doi: 10.1186/1472-6947-10-71.
    • Toddenroth D, Dugas M, Kennerknecht I. . ‘Sorting chromosomes as a software-based exercise.Med Educ 44, Nr. 11: 1127. doi: 10.1111/j.1365-2923.2010.03845.x.
    • Bartenhagen C, Klein HU, Ruckert C, Jiang X, Dugas M. . ‘Comparative study of unsupervised dimension reduction techniques for the visualization of microarray gene expression data.’ BMC Bioinformatics 11: 567-577. doi: 10.1186/1471-2105-11-567.
    • Dugas-Breit S, Przybilla B, Dugas M, Arnold A, Pfundstein G, Küchenhoff H, Ruëff F. . ‘Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.Clin Exp Allergy 40, Nr. 4: 643-9. doi: 10.1111/j.1365-2222.2009.03436.x.
    • Hömme C, Krug U, Tidow N, Schulte B, Kühler G, Serve H, Bürger H, Berdel WE, Dugas M, Heinecke A, Büchner T, Koschmieder S, Müller-Tidow C. . ‘Low SMC1A protein expression predicts poor survival in acute myeloid leukemia.Oncol Rep 24, Nr. 1: 47-56.
    • Dugas M, Lange M, Müller-Tidow C, Kirchhof P, Prokosch HU. . ‘Routine data from hospital information systems can support patient recruitment for clinical studies.Clin Trials 7, Nr. 2: 183-9. doi: 10.1177/1740774510363013.
    • Malyar V, Busch V, Hillebrand U, Reiermann S, Kliche K, Breil B, Dugas M, Suwelack B. . ‘PROGNOSTIC FACTORS FOR AND PREVALENCE OF BK-VIRUS INFECTION IN A CAUCASIAN RENAL TRANSPLANT POPULATION.’ Transpl Int 23 Suppl.: 0112 -.
    • Dugas M, Breil B, Thiemann V, Lechtenbörger J, Vossen G. . ‘Single Source Informationssysteme - Nutzung von Routinedaten für die klinische Forschung.’ Contributed to the 54. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS), Essen. doi: 10.3205/09gmds287.
    • Breil B, Semjonow A, Dugas M. . ‘HIS-based electronic documentation can significantly reduce the time from biopsy to final report for prostate tumours and supports quality management as well as clinical research.’ BMC Med Inform Decis Mak. 9, Nr. 1: 5.
    • Dugas M, Thun S, Frankewitsch T, Heitmann KU. . ‘LOINC® Codes for Hospital Information System documents - a case study.’ J Am Med Inform Assoc 16, Nr. 3: 400-403.
    • Breil B, Dugas M. . ‘Transferring HIS data to population-based cancer registries - concept and first implementations.’ Stud Health Technol Inform 150: 86-90.
    • Dugas M, Breil B, Thiemann V, Lechtenbörger J, Vossen G. . ‘Single Source Information Systems to Connect Patient Care and Clinical Research.’ In Medical Informatics in a United and Healthy Europe - Proceedings of MIE 2009 – The XXIInd International Congress of the European Federation for Medical Informatics, edited by Klaus-Peter Adlassnig, Bernd Blobel, John Mantas, Izet Masic, 61-65.: IOS Press. doi: 10.3233/978-1-60750-044-5-61.
    • Schäfer M, Schwender H, Merk S, Haferlach C, Ickstadt K, Dugas M. . ‘Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities.Bioinformatics 25, Nr. 24: 3228-35. doi: 10.1093/bioinformatics/btp592.
    • Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, Hotfilder M, Marra A, Koschmieder S, Dugas M, Berdel WE, Serve H, Müller-Tidow C. . ‘S100A2 induces metastasis in non-small cell lung cancer.Clinical Cancer Research 15, Nr. 1: 22-9. doi: 10.1158/1078-0432.CCR-08-0953.
    • Akagi T, Ogawa S, Dugas M, Kawamata N, Yamamoto G, Nannya Y, Sanada M, Miller CW, Yung A, Schnittger S, Haferlach T, Haferlach C, Koeffler HP. . ‘Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.Haematologica 94, Nr. 2: 213-23. doi: 10.3324/haematol.13024.
    • Krug U, Yasmeen A, Beger C, Bäumer N, Dugas M, Berdel WE, Müller-Tidow C. . ‘Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.International Journal of Oncology 34, Nr. 1: 129-36.
    • Dugas M, Amler S, Lange M, Gerss J, Breil B, Köpcke W. . ‘Estimation of patient accrual rates in clinical trials based on routine data from hospital information systems.Methods of Information in Medicine 48, Nr. 3: 263-6. doi: 10.3414/ME0582.
    • Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP. . ‘High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.Molecular cancer research 7, Nr. 5: 665-77. doi: 10.1158/1541-7786.MCR-08-0270.
    • Nowak D, Kawamata N, Niebuhr B, Nowak V, Mossner M, Nahar RR, Thoennissen NH, Iwanski GB, Stocking C, Dugas M, Hofmann WK, Muschen M, Koeffler PH. . ‘The Pax5 Fusion Product Pax5-C20orf112 Causes Downregulation of Pre-B Cell Receptor Genes and Induces Differential Proliferation Patterns in B-Lymphoblastic Cell Lines.’ Blood 114, Nr. 22: 526-527.
    • Haferlach T, Kohlmann A, Klein HU, Ruckert C, Dugas M, Williams PM, Kern W, Schnittger S, Bacher U, Löffler H, Haferlach C. . ‘AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.’ Leukemia 23, Nr. 5: 934-943. doi: 10.1038/leu.2008.388.
    • Akagi T, Shih LY, Ogawa S, Gerss J, Moore SR, Schreck R, Kawamata N, Liang DC, Sanada M, Nannya Y, Deneberg S, Zachariadis V, Nordgren A, Song JH, Dugas M, Lehmann S, Koeffler HP. . ‘Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.Haematologica 94, Nr. 9: 1301-6. doi: 10.3324/haematol.2009.005744.
    • Dugas M, Eckholt M, Bunzemeier H. . ‘Benchmarking of hospital information systems: monitoring of discharge letters and scheduling can reveal heterogeneities and time trends.BMC Medical Informatics and Decision Making 8: 15. doi: 10.1186/1472-6947-8-15.
    • Dugas M, Lange M, Berdel WE, Müller-Tidow C. . ‘Workflow to improve patient recruitment for clinical trials within hospital information systems - a case-study.Trials 9: 2. doi: 10.1186/1745-6215-9-2.
    • Heer IM, Kumper C, Vogtle N, Muller-Egloff S, Dugas M, Strauss A. . ‘Analysis of factors influencing the ultrasonic fetal weight estimation.Fetal Diagnosis and Therapy 23, Nr. 3: 204-10. doi: 10.1159/000116742.
    • Isken F, Steffen B, Merk S, Dugas M, Markus B, Tidow N, Zühlsdorf M, Illmer T, Thiede C, Berdel WE, Serve H, Müller-Tidow C. . ‘Identification of acute myeloid leukaemia associated microRNA expression patterns.British Journal of Haematology 140, Nr. 2: 153-61.
    • Kohlmann A, Bullinger L, Thiede C, Schaich M, Schnittger S, DohnerMd K, Dugas M, Dohner H, Ehninger G, Haferlach T. . ‘Gene Expression Profiling in AML with Normal Karyotype: A Multicenter Study Investigating Molecular Markers in 252 Cases.’ Blood 112, Nr. 11: 278-279.
    • Merk S, Dugas M. . ‘Application of microarray technology for the analysis of gene expression in veterinary medicine.Berl. Münch. Tierärztl. Wochenschr : 179-188.
    • Müller-Tidow C, Dugas M. . ChIP- chip microarrays to study the epigenome in leukemia European Leukemia Network of Excellence, Information Letter, Nr. 5, .
    • Russ AC, Dugas M, Schmid-Fetzer SC, Schlenk RF, Pollack JR, Dohner K, Schmid M, Dohner H, Bullinger L.Combined Analysis of Valproic Acid Induced MicroRNA and Gene Expression Changes in Acute Myeloid Leukemia.“ contributed to the ASH 2007, .
    • Haferlach T, Haferlach C, Kohlmann A, Wieczorek L, Dugas M, Merk S, Kern W, Schnittger S. . ‘Microarray analysis detects unique expression pattern for NPM1-mutated AML with normal karyotype and reveals pathobiological insights.’ Blood 110, Nr. 11: 2382.
    • Akagi T, Ogawa S, Yamamoto G, Nannya Y, Sanada M, Kawamata N, Miller CW, Dugas M, Schnittger S, Haferlach T, Haferlach C, Koeffler HP. . ‘Numerous genomic abnormalities in AML with normal karyotype.’ Blood 110, Nr. 11: 1811.
    • Haferlach C, Rauhut S, Merk S, Dicker F, Schnittger S, Kern W, Dugas M, Haferlach T. . ‘Translocation t(14;19)(q32;q13) is a rare abnormality in CLL and associated with trisomy 12, an unmutated IgVH status and a distinct gene expression profile.’ Blood 110, Nr. 11: 4703.
    • Haferlach C, Merk S, Rauhut S, Schnittger S, Kern W, Dugas M, Haferlach T. . ‘An approach to virtual karyotyping for unbalanced rearrangements based on gene expression data.’ Blood 110, Nr. 11: 885.
    • Haferlach C, Raubut S, Merk S, Dicker F, Schnittger S, Kern W, Dugas M, Haferlach T. . ‘Gain of the short arm of chromosome 2 is a new recurring chromosome aberration in CLL which is significantly associated with an unmutated IgGVH status and a complex aberrant karyotype and leads to a higher expression of genes located on 2P.’ Blood 110, Nr. 11: 2075.
    • Haferlach T, Haferlach C, Kohlmann A, Wieczorek L, Dugas M, Merk S, Kern W, Schnittger S.Microarray Analysis Detects Unique Expression Pattern for NPM1-Mutated AML with Normal Karyotype and Reveals Pathobiological Insights.“ contributed to the ASH 2007, .
    • Akagi T, Ogawa S, Yamamoto G, Nannya Y, Sanada M, Kawamata N, Miller CW, Dugas M, Schnittger S, Haferlach T, Haferlach C, Koeffler HP.Numerous Genomic Abnormalities in AML with Normal Karyotype.“ contributed to the ASH 2007, .
    • Haferlach C, Merk S, Rauhut S, Schnittger S, Kern W, Dugas M, Haferlach T.An Approach to Virtual Karyotyping for Unbalanced Rearrangements Based on Gene Expression Data.“ contributed to the ASH 2007, .
    • Haferlach C, Rauhut S, Merk S, Dicker F, Schnittger S, Kern W, Dugas M, Haferlach T.Gain of the Short Arm of Chromosome 2 Is a New Recurring Chromosome Aberration in CLL Which Is Significantly Associated with an Unmutated IgGVH Status and a Complex Aberrant Karyotype and Leads to a Higher Expression of Genes Located on 2P.“ contributed to the ASH 2007, .
    • Vempati S, Reindl C, Kaza SK, Kern R, Malamoussi T, Dugas M, Mellert G, Schnittger S, Hiddemann W, Spiekermann K. . ‘Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential.’ Blood 110, Nr. 2: 686-694. doi: 10.1182/blood-2006-10-053181.
    • Haferlach C, Rauhut S, Merk S, Dicker F, Schnittger S, Kern W, Dugas M, Haferlach T. . ‘Translocation t(14;19)(q32;q13) Is a Rare Abnormality in CLL and Associated with Trisomy 12, an Unmutated IgVH Status and a Distinct Gene Expression Profile.’ Contributed to the ASH 2007.
    • Schoch C, Kohlmann A, Dugas M, Kern W, Schnittger S, Haferlach T. . ‘Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups.’ Genes Chromosomes Cancer 45, Nr. 12: 1164-1168.
    • Dugas M, Weninger F, Merk S, Kohlmann A, Haferlach T. . ‘A Generic Concept for Large-scale Microarray Analysis Dedicated to Medical Diagnostics.’ Methods Inf Med 45, Nr. 2: 146-152.
    • Dugas-Breit S, Schopf P, Dugas M, Schiffl H, Rueff F, Przybilla B. . ‘Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus.J Dtsch Dermatol Ges 3, Nr. 5: 343-347.
    • Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C. . ‘AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.Genes Chromosomes Cancer 43, Nr. 2: 113-127.
    • Chouker A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I, Setzer F, Rau HG, Lohe F, Jauch KW, Peter K, Thiel M. . ‘Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection.World J Surg 29, Nr. 4: 528-534.
    • Bocionek S, Dugas M. . ‘Hospital Information Systems.’ In Imaging Systems for Medical Diagnostics, 943-989. Publicis Publishing.
    • Trumm C, Dugas M, Wirth S, Treitl M, Lucke A, Kuttner B, Pander E, Clevert DA, Glaser C, Reiser M. . ‘Digital teaching file Concept, implementation, and experiences in a university setting.Radiologe 45, Nr. 8: 724-734.
    • Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, Haferlach T. . ‘Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.Leukemia 19, Nr. 7: 1224-1228.
    • Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C. . ‘Global approach to the diagnosis of leukemia using gene expression profiling.Blood 106, Nr. 4: 1189-1198.
    • Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kaab S, Hinterseer M, Kartmann H, Kreuzer E, Dugas M, Steinbeck G, Nabauer M. . ‘Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature.Circ Res 96, Nr. 9: 1022-1029.
    • Kohlmann A, Schoch C, Dugas M, Rauhut S, Weninger F, Schnittger S, Kern W, Haferlach T. . ‘Pattern robustness of diagnostic gene expression signatures in leukemia.Genes Chromosomes Cancer 42, Nr. 3: 299-307.
    • Kohlmann A, Schoch C, Dugas M, Schnittger S, Hiddemann W, Kern W, Haferlach T. . ‘New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes.Leukemia 19, Nr. 6: 953-964.
    • Dugas M, Merk S, Breit S, Dirschedl P. . ‘mdclust - Exploratory Microarray Analysis by Multidimensional Clustering.Bioinformatics 20, Nr. 6: 931-936.
    • Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, Dierkes N, Westner IM, Kretzschmar HA. . ‘Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology.J Virol 78, Nr. 20: 11051-11060.
    • Kaab S, Barth AS, Margerie D, Dugas M, Gebauer M, Zwermann L, Merk S, Pfeufer A, Steinmeyer K, Bleich M, Kreuzer E, Steinbeck G, Nabauer M. . ‘Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure.J Mol Med 82, Nr. 5: 308-316.
    • Chouker A, Martignoni A, Dugas M, Eisenmenger W, Schauer R, Kaufmann I, Schelling G, Lohe F, Jauch KW, Peter K, Thiel M. . ‘Estimation of liver size for liver transplantation: the impact of age and gender.Liver Transpl 10, Nr. 5: 678-685.
    • Chouker A, Schachtner T, Schauer R, Dugas M, Lohe F, Martignoni A, Pollwein B, Niklas M, Rau HG, Jauch KW, Peter K, Thiel M. . ‘Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial.Br J Anaesth 93, Nr. 2: 204-211.
    • Heer IM, Middendorf K, Muller-Egloff S, Dugas M, Strauss A. . ‘Ultrasound training: the virtual patient.Ultrasound Obstet Gynecol 24, Nr. 4: 440-444.
    • Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T. . ‘Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients.’ Leukemia 18, Nr. 1: 63-71.
    • Martin-Sanchez F, Iakovidis I, Nørager S, Maojo V, de Groen P, van der Lei J, Jones T, Abraham-Fuchs K, Apweiler R, Babic A, Baud R, Breton V, Cinquin P, Doupi P, Dugas M, Eils R, Engelbrecht R, Ghazal P, Jehenson P, Kulikowski C, Lampe K, de Moor G, Orphanoudakis S, Rossing N, Sarachan B, Sousa A, Spekowius G, Thireos G, Zahlmann G, Zvarova J, Hermosilla I, Vicente FJ. . ‘Synergy between medical informatics and bioinformatics: facilitating genomic medicine for future health care.’ Journal of Biomedical Informatics 37, Nr. 1: 30-42.
    • Hoffmann R, Seidl T, Bruno L, Dugas M. . ‘Developmental markers of B cells are superior to those of T cells for identification of stages with distinct gene expression profiles.J Leukoc Biol 74, Nr. 4: 602-610. doi: 10.1189/jlb.0203085.
    • Dugas M, Weinzierl S, Pecar A, Endres S, Hasford J. . ‘Design and implementation of a common drug information database for a university hospital.’ Pharm World Sci 25, Nr. 4: 156-161.
    • Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E. . ‘Transvenous defibrillation leads: high incidence of failure during long-term follow-up.’ J Cardiovasc Electrophysiol 14, Nr. 1: 38-43.
    • Dugas M, Merk S, Breit S, Schoch C, Haferlach T, Kääb S. . ‘Bioinformatics for Medical Diagnostics: Assessment of Microarray Data in the Context of Clinical Databases.’ Contributed to the AMIA 2003 Annual Symposium.
    • Reithmann C, Hahnefeld A, Remp T, Dorwarth U, Dugas M, Steinbeck G, Hoffmann E. . ‘Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia.’ Pacing Clin Electrophysiol 26, Nr. 6: 1308-1316.
    • Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T. . ‘Molecular characterization of acute leukemias by use of microarray technology.’ Genes, Chromosomes and Cancer 37: 396-405.
    • Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlöndorff D, Plewig G, Sander C, Röcken M. . ‘Interleukin 4-therapy of psoriasis induces Th2-responses and improves human autoimmune disease.’ Nature Medicine 9, Nr. 1: 40-46. doi: 10.1038/nm804.
    • Reithmann C, Dorwarth U, Dugas M, Hahnefeld A, Ramamurthy S, Remp T, Steinbeck G, Hoffmann E. . ‘Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.’ Eur Heart J 24, Nr. 13: 1264-1272.
    • Dorwarth U, Fiek M, Remp T, Reithmann C, Dugas M, Steinbeck G, Hoffmann E. . ‘Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles.Pacing Clin Electrophysiol : 1438-1445.
    • Dugas M, Messerer D, Hasford J, Haferlach T, Heinze B, Ludwig W, Rieder H, Schoch R, Schwartz S, Thiel E. . ‘The German Multicentre Study Group for Adult ALL (GMALL): Recruitment in comparison to ALL incidence and its impact on study results.’ Annals of Hematology 82: 83-87.
    • Svaldi M, Lanthaler AJ, Dugas M, Lohse P, Pescosta N, Straka C, Mitterer M. . ‘T-cell receptor excision circles: a novel prognostic parameter for the outcome of transplantation in multiple myeloma patients.’ Br J Haematol 122, Nr. 5: 795-801.
    • Hege I, Radon K, Dugas M, Scharrer E, Nowak D. . ‘Web-based training in occupational medicine.’ International Archives of Occupational and Environmental Health 76: 50-54.
    • Schoch C, Schnittger S, Kern W, Dugas M, Hiddemann W, Haferlach T. . ‘Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia.Haematologica 88, Nr. 3: 351-352.
    • Hoffmann R, Seidl T, Dugas M. . ‘Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis.Genome Biol 3, Nr. 7. doi: 10.1186/gb-2002-3-7-research0033.
    • Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. . ‘Analysis of FLT3 length mutations in 1003 patients with AML: relation to cytogenetics, fab subtype, and prognosis in the AMLCG-study and usefullness as a marker for detection of minimal residual disease.’ Blood 100, Nr. 1: 59-66.
    • Dugas M, Hoffmann E, Janko S, Hahnewald S, Matis T, Miller J, v Bary C, Farnbacher A, Vogler V, Überla K. . ‘Complexity of Biomedical Data Models in Cardiology: The Intranet-based Atrial Fibrillation Registry.’ Computer Methods and Programs in Biomedicine 68: 49-61.
    • Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, Bittmann I, Dugas M, Reiser M. . ‘Detection of Malignant Hepatic Lesions Before Orthotopic Liver Transplantation: Accuracy of Ferumoxides-Enhanced MR Imaging.Am J Roentgenol 179, Nr. 4: 1045-1051.
    • Kufer P, Zippelius A, Lutterbüse R, Mecklenburg I, Enzmann T, Montag A, Weckermann D, Passlick B, Prang N, Reichardt P, Dugas M, Köllermann MW, Pantel K, Riethmüller G. . ‘Heterogeneous Expression of MAGE-A Genes in Occult Disseminated Tumor Cells: A novel multimarker RT-PCR for diagnosis of micrometastatic disease.’ Cancer Research 62: 251-261.
    • Dugas M, Schoch C, Schnittger S, Kohlmann A, Kern W, Haferlach T, Überla K. . ‘Impact of integrating clinical and genetic information.’ Silico Biology .
    • Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Loffler H, Hiddemann W. . ‘Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.Genes Chromosomes Cancer 35: 20-29.
    • Dugas M, Schauer R, Volk A, Rau H. . ‘Interactive decision support in hepatic surgery.BMC Med Inform Decis Mak 2, Nr. 1.
    • Dugas M. . „Datenerhebung im Internet - Potential, Probleme und Perspektiven.“ In Moderne Gesundheitskommunikation - Von der Arzt-Patient-Interaktion zur E-Health. Verlag Hans Huber.
    • Dugas M, Reng M. . ‘XML-based Knowledge Management for Teleteaching and Telelearning in Medicine.’ Contributed to the 7th International Conference on the Medical Aspects of Telemedicine: Integration of Health Telematics into Medical Practice.
    • Dugas M, Christ F, Demetz F, Batschkus M, Überla K. . ‘Interactive Computer-Based-Training in Medicine - an example from Emergency Medicine.’ Contributed to the Proceedings of the Slice of Life 2001 & Computers in Healthcare Symposium, Berlin.
    • Schoch C, Kern W, Krawitz P, Dugas M, Schnittger S, Haferlach T, Hiddemann W. . ‘Dependence of age-specific incidence of acute myeloid leukemia on karyotype.’ Blood 98: 3500.
    • Dugas M, Hoffmann E, Janko S, Hahnewald S, Matis T, Überla K. . ‘XML-based Visual Data Mining in Medicine.’ Medinfo 10, Nr. 2: 1324-1328.
    • Dugas M, Kuhn K, Kaiser N, Überla K. . ‘XML-based visualization of design and completeness in medical databases.’ Medical Informatics and the Internet in Medicine 26: 237-250.
    • Dugas M, Weinzierl S, Pecar A, Hasford J. . ‘Intranet Database for a University Hospital Drug Information Center.’ American Journal of Health-System Pharmacy 58: 799-802.
    • Dugas M, Trumm C, Stäbler A, Pander E, Hundt W,,Scheidler J, Brüning R, Helmberger T, Waggershauser T, Matzko M, Reiser M. . ‘Case-oriented computer-based-training in radiology: concept, implementation and evaluation.’ BMC Medical Education .
    • Radon K, Hege I, Scharrer E, Dugas M, Fischer M, Nowak D. . „Vorstellung des computerunterstützten Lernprogramms „Co-LAB“ für das Fach Arbeitsmedizin.“ Beitrag präsentiert auf der 41. Jahrestagung der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V..
    • Dugas M , Schoch C, Schnittger S, Kern W, Haferlach T, Messerer D, Überla K. . ‘Impact of integrating clinical and genetic information.’ Contributed to the German Conference on Bioinformatics (GCB 2001).
    • Dugas M. . „Perspektiven für ein patientenorientiertes Informations- und Kommunikationsmanagement durch das Computerbasierte Patientendossier.“ Beitrag präsentiert auf der Schweizerischen Gesellschaft für Medizinische Informatik, Basel.
    • Dugas M, Schoch C, Schnittger S, Haferlach T, Danhauser-Riedl S, Hiddemann W, Messerer D, Überla K. . ‘A comprehensive leukemia database: Integration of cytogenetics, molecular genetics and microarray data with clinical information, cytomorphology and immunphenotyping.’ Leukemia 15: 1805-1810.
    • Dugas M, Überla K. . ‘An Intranet Tool for XML-based Data Modelling in Medicine.’ Medical Infobahn for Europe 2000, Nr. 77: 983-987.
    • Dugas M, Demetz F, Christ F. . „Online-Kurs Notfallmedizin: Kurrikulare Integration von Computer-Based-Training.“ Anaesthesist 2000, Nr. 49: 881-886.
    • Dugas M, Scheichenzuber J, Hornung H. . ‘An Intranet-Based System for Quality Assurance in Surgery.J Med Syst 23, Nr. 1: 13-19.
    • Dugas M, Noachtar S. . ‘Computer-Based-Training in der Neurologie mit Intranet-Technik am Beispiel Epilepsie. Biomedical Journal 1999, 53(1), 27-29.’ Biomedical Journal 53, Nr. 1: 27-29.
    • Dugas M, Batschkus MM, Lyon HC Jr. . ‘Mr. Lewis on the web - how to convert learning resources for intranet-technology.’ Medical Education 33, Nr. 1: 42-46.
    • Dugas M, Überla K. . ‘Intranet Based Clinical Workstations.’ In Medical Informatics, Biostatistics and Epidemiology for Efficient Health Care and Medical Research, 235-238. München: Urban und Vogel.
    • Dugas M, Bosch R, Paulus R, Lenz T. . ‘Intranet-based multi-purpose medical records in Orthopedics.’ Medical Informatics 24, Nr. 4: 269-275.
    • Heitmann KU, Morzinck T, Mösges R, Dugas M. . „Intranet-Anwendungen am Universitätsklinikum Köln.“ In Herausforderungen in der Informationsverarbeitung an den Universitäten des Landes NRW, 58-65. Aachen: Shaker Verlag.
    • Dugas M, Demant T. . „Intranet-Technologie für die Medizinische Ausbildung am Beispiel Klinische Chemie.“ Medizinische Ausbildung 1998, Nr. 60: 27-30.
    • Lyon HC Jr, Longnecker DS, Gonzalez J, O'Donnell J, Bell JR, Izzo D, Ueberla K, Batschkus M, Dugas M, Fischer M, Eitel F, Weindl A, Shultz E. . ‘Correlation between student use of computer-based instruction and high exam scores in pathology.’ Journal of Medical Education Technologies 1998, Nr. 6: 20-25.
    • Dugas M. . ‘An intranet-based information system for nurses.’ MD Computing 15, Nr. 3: 158-161.
    • Dugas M, Jacobs P. . Pflegeinformationen per Computer.
    • Batschkus MM, Gumpinger M, Dugas M. . „Innovative Lösungen für eine transparente Nutzerführung zu Online- und Offline-Angeboten an Lernstationen für Studenten.“ In Computer Based Training in der Medizin Technik - Evaluation-Implementation. Aachen: Shaker Verlag.
    • Dugas M. . „HTML-Anwendungen im Intranet - Erfahrungen im Klinikum Großhadern.“ In Kongreßband der XII. Jahrestagung der SGMI/SSIM. Klinikinformationssysteme von der Theorie zur Praxis, 114-118. Zürich.
    • Dugas M. . ‘Clinical applications of Intranet-Technology.’ In New Technologies in Hospital Information Systems, 115-118. IOS Press.
    • Dugas M, Überla K. . „Bereitstellung und Nutzung medizinischer Inhalte mit einem universellen Klinikinformationsserver des IBE - Erfahrungen auf 50 Stationen im Klinikum Großhadern.“ In Medizinische Informatik, Biometrie und Epidemiologie, 40-43. München: MMV-Verlag.
    • Dugas M. . „Kommunikation im Gesundheitswesen: HTML-Anwendungen im Intranet.“ In Medizinische Dokumentation und Information, 1-21.
    • Dugas M, Batschkus MM, Lyon HC. . „CBT in der Medizin mit Intranet-Technologie - Erfahrungen im Klinikum Großhadern.“ In CBT in der Medizin, 17-20. Aachen.
    • Zong XG, Dugas M, Honerjäger P. . ‘Relation between Veratridine Reaction Dynamics and Macroscopic Na Current in Single Cardiac Cells.J Gen Physiol 1992, Nr. 99: 683-697.
    • Honerjäger P, Dugas M, Zong XG. . ‘Mutually Exclusive Action of Cationic Veratridine and Cevadine at an Intracellular Site of the Cardiac Sodium Channel.J Gen Physiol 1992, Nr. 99: 699-720.
    • Wang G, Dugas M, Armah IB, Honerjäger P. . ‘Sodium Channel Comodification with Full Activator reveals Veratridine Reaction Dynamics.Molecular Pharmacology 1990, Nr. 37: 144-148.
    • Wang G, Dugas M, Armah IB, Honerjäger P. . ‘Interaction between DPI 201-106 Enantiomers at the Cardiac Sodium Channel.Molecular Pharmacology 1990, Nr. 37: 17-24.
    • Dugas M, Honerjäger P, Masslich U. . ‘Tetrodotoxin block of single germitrine-activated sodium channels in cultured rat cardiac cells.J Physiol 1989, Nr. 411: 611-626.
  • Betreute Arbeiten

    Betreute Promotionen

    Niemeyer, SinaDokumentation der chronischen Prurigo
    Blitz, RogerioRogerio BlitzGenerischer, standardkonformer Metadaten und Datentransfer in die elektronische Patientenakte
    Wünsch, ChristianAMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
    Wöste, MariusAlgorithmen zur sensitiven und spezifischen Detektion von MDS-Mutationen
    Holz, ChristianCommon Data Element Analysis & Harmonization for Acute Myeloid Leukemia
    Kentgen, MarkusCommon Data Element Analysis & Harmonization for Acute Coronary Syndrome
    Walter, CarolinAnalyse von NGS-und 4C-seq-Daten
    Suilmann, Theresa AntoniaUsability of validated sleep-assessment questionnaires in patients with chronic pruritus
    Sandmann, SarahEvaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data
    Gernart, MarvinItchApp : An App-based eDiary for Assessment of Chronic Pruritus in Clinical Trials
    Gernart, MarvinItchApp : An App-based eDiary for Assessment of Chronic Pruritus in Clinical Trials
    Storck, MichaelODMSummary: A tool for automatic structured comparison of multiple medical forms based on semantic annotation with the Unified Medical Language System
    Mamuzic, Jasmina"Mobile Health als Teil der modernen Medizin Anforderungen aus Sicht der Bevölkerung"
    Soto Rey, IñakiEfficiency and effectiveness evaluation of an automated multi-country patient count cohort system
    Warlich, BenjaminHealth-Related Quality of Life in Chronic Pruritus: An Analysis Related to Disease Etiology, Clinical Skin Conditions and Itch Intensity
    Tilahun, BinyamElectronic medical record system framework for low resource setting hospitals
    Butz, OlafEvaluation des Bilddatenaustausches im Traumanetzwerk NordWest Einflüsse auf Prozesse in der Notaufnahme
    Neuhaus, PhilippCharacterization of Image Transfer Patterns in a Regional Trauma Network
    Bruland, PhilippDoes single-source create an added value? Evaluating the impact of introducing x4T into the clinical routine on workflow modifications, data quality and cost-benefit.
    Bartenhagen, ChristophRobuste und genaue Detektion struktureller Varianten mit Paired-End- und Soft-Clip-Alignments: SoftSV im Vergleich mit acht Algorithmen
    Heide, TobiasResearch Portals - Knowledge Access, Content Design, and Quality Management
    Trinczek, BenjaminDesign and multicentric implementation of a generic software architecture for patient recruitment systems re-using existing HIS tools and routine patient data
    Doods, JustinA European inventory of common electronic health record data elements for clinical trial feasibility
    Krumm, RainerThe need for harmonized structured documentation and chances of secondary use
    Bruland, PhilippDoes single-source create an added value? Evaluating the impact of introducing x4T into the clinical routine on workflow modifications, data quality and cost-benefit.
    Varghese, JulianFrequency analysis of medical concepts in clinical trials and their coverage in MeSH and SNOMED-CT
    Koch, RaphaelBayesianische Verfahren in pädiatrischen Studien Extrapolation historischer Informationen aus klinischen Studien an Erwachsenen und Kindern: Ergebnisse, Limitationen und Erweiterungen eines meta-analytisch prädiktiven Ansatzes
    Hebestreit, KatjaDetection of significantly differentially methylated regions in targeted bisulfite sequencing data
    Fritz, FleurQualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency
    Breil, BernhardKIS-basierte Kaplan-Meier Kurven - Ein Single-Source Ansatz für die Dokumentation und Wiederverwendung von Überlebenszeitdaten
    Klein, Hans-UlrichQuantitative comparison of microarray experiments with published leukemia related gene expression signatures
    Herzberg, SusanneKonzept und Implementierung eines Single Source Informationssystems in der Nuklearmedizin
    Eminaga, OkyazClinical map document based on XML (cMDX) - document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

    Betreute Habilitationen

    Schmidt, ReneKonfirmatorische adaptive Designs für Phase II Studien mit Überlebenszeitendpunkt
    Majchrzak, Tim AlexanderSoftware Engineering für mobile Endgeräte
    Reitz, ChristianeVascular Disease and Cognitive Impairment